drugset / Trial / NCT06717269

Relative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets

NCT06717269

Phase 1 Recruiting 18 enrolled Nurix Therapeutics, Inc.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

This is a multiple part, multiple cohort study evaluating the relative bioavailability, food effect, and drug-drug interaction of NX-5948 in healthy volunteers.

Timeline

Start
2024-11-30
Primary completion
2026-04
Completion
2026-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule Oral
Subject NX-5948 Other / unclassified Oral

Indications

No indication recorded.